Cargando…

Inhaled hypertonic saline in adults hospitalised for exacerbation of cystic fibrosis lung disease: a retrospective study

BACKGROUND: Inhaled hypertonic saline (HTS) improves quality of life and reduces pulmonary exacerbations when given long term in patients with cystic fibrosis (CF). While increasingly being offered for acute pulmonary exacerbations, little is known about the efficacy in this setting. OBJECTIVES: The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pezzulo, Alejandro A, Stoltz, David A, Hornick, Douglas B, Durairaj, Lakshmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2012
Materias:	Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332252/ https://www.ncbi.nlm.nih.gov/pubmed/22517980 http://dx.doi.org/10.1136/bmjopen-2011-000407

Ejemplares similares

Stratified assessment of the role of inhaled hypertonic saline in reducing cystic fibrosis pulmonary exacerbations: a retrospective analysis
por: Dmello, Dayton, et al.
Publicado: (2011)

Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis
por: Laube, Beth L, et al.
Publicado: (2011)

Hypertonic Saline in Treatment of Pulmonary Disease in Cystic Fibrosis
por: Reeves, Emer P., et al.
Publicado: (2012)

Hypertonic saline releases the attached small intestinal cystic fibrosis mucus
por: Ermund, Anna, et al.
Publicado: (2015)

A Physiologically-Motivated Compartment-Based Model of the Effect of Inhaled Hypertonic Saline on Mucociliary Clearance and Liquid Transport in Cystic Fibrosis
por: Markovetz, Matthew R., et al.
Publicado: (2014)

Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice
por: Terlizzi, Vito, et al.
Publicado: (2021)

Utilisation, expenditure and cost-effectiveness of cystic fibrosis drugs in Ireland: a retrospective analysis of a national pharmacy claims database
por: Smith, Amelia, et al.
Publicado: (2020)

The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2020)

Assessing medication use patterns in patients hospitalised with COVID-19: a retrospective study
por: Mueller, Tanja, et al.
Publicado: (2022)

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation
por: Rakhshan, Amin, et al.
Publicado: (2023)

Rheological effects of hypertonic saline and sodium bicarbonate solutions on cystic fibrosis sputum in vitro
por: Budai-Szűcs, Mária, et al.
Publicado: (2021)

Predicting opioid-induced oversedation in hospitalised patients: a multicentre observational study
por: Garrett, John, et al.
Publicado: (2021)

Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial
por: Nenna, Raffaella, et al.
Publicado: (2017)

Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis
por: Ullah, Saad Ehsan, et al.
Publicado: (2023)

Pharmacological interventions to improve sleep in hospitalised adults: a systematic review
por: Kanji, Salmaan, et al.
Publicado: (2016)

Advances toward the Elucidation of Hypertonic Saline Effects on Pseudomonas aeruginosa from Cystic Fibrosis Patients
por: Michon, Anne-Laure, et al.
Publicado: (2014)

How are drug regimen changes during hospitalisation handled after discharge: a cohort study
por: Viktil, Kirsten K, et al.
Publicado: (2012)

Retrospective cohort study to evaluate medication use in patients hospitalised with COVID-19 in Scotland: protocol for a national observational study
por: Mueller, Tanja, et al.
Publicado: (2021)

The effectiveness of hyaluronic acid in reducing adverse effects associated with inhaled hypertonic saline therapy in patients with cystic fibrosis: A systematic review and meta-analysis
por: Arshid, Sana, et al.
Publicado: (2023)

Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions
por: Miller, Aaron C., et al.
Publicado: (2020)

Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study
por: O'Neill, Katherine, et al.
Publicado: (2017)

Comment on “Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis”
por: Gutierrez-Arias, Ruvistay, et al.
Publicado: (2023)

Hypertonic saline solutions do not influence the solubility of sputum from secretor and non-secretor cystic fibrosis patients
por: Barboza, Marcelo A.I., et al.
Publicado: (2011)

Nature of adverse events with opioids in hospitalised patients: a post-hoc analysis of three patient record review studies
por: Schutijser, Bernadette Clara Francisca Maria, et al.
Publicado: (2020)

Clinical and economic impact of adverse drug reactions in hospitalised patients: prospective matched nested case–control study in Ethiopia
por: Sendekie, Ashenafi Kibret, et al.
Publicado: (2023)

Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis
por: Schultz, Andre, et al.
Publicado: (2019)

Role of Tiotropium in Reducing Exacerbations of Chronic Obstructive Pulmonary Disease When Combined With Long‐Acting β (2)‐Agonists and Inhaled Corticosteroids: The OUTPUL Study
por: Ferroni, Eliana, et al.
Publicado: (2016)

Acute and durable effect of inhaled hypertonic saline on mucociliary clearance in adult asthma
por: Bennett, William D., et al.
Publicado: (2021)

Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems
por: Kaufmann, Carole P, et al.
Publicado: (2018)

Prevalence of hospitalisation caused by adverse drug reactions at an internal medicine ward of a single centre in Japan: a cross-sectional study
por: Komagamine, Junpei, et al.
Publicado: (2019)

Nebulized hypertonic saline triggers nervous system-mediated active liquid secretion in cystic fibrosis swine trachea
por: Luan, Xiaojie, et al.
Publicado: (2019)

COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline
por: Seyedi, Seyed Javad, et al.
Publicado: (2022)

A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD
por: Jara, Michele, et al.
Publicado: (2012)

Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review
por: Máiz Carro, Luis, et al.
Publicado: (2019)

Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex
por: Fraser-Pitt, Douglas, et al.
Publicado: (2016)

From hospitalisation to primary care: integrative model of clinical pharmacy with patients implanted with a PICC line—research protocol for a prospective before–after study
por: Pouget, Alix Marie, et al.
Publicado: (2021)

Bone mineral density and fracture risk with long-term use of inhaled corticosteroids in patients with asthma: systematic review and meta-analysis
por: Loke, Yoon K, et al.
Publicado: (2015)

Nursing Progress of Hypertonic Saline Inhalation in the Treatment of Infantile Bronchitis Based on Image Enhancement
por: Li, Haiyan, et al.
Publicado: (2022)

Hypertonic Saline Therapy in Cystic Fibrosis: Do Population Shifts Caused by the Osmotic Sensitivity of Infecting Bacteria Explain the Effectiveness of this Treatment?
por: Williams, Huw D., et al.
Publicado: (2010)

Hypertonic saline resuscitation in sepsis
por: Wade, Charles E
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_k1bnnb7sfdpqqr64ufoi744sh2